Exam 8: Managing in Competitive, Monopolistic, and Monopolistically Competitive Markets
Exam 1: The Fundamentals of Managerial Economics143 Questions
Exam 2: Market Forces: Demand and Supply150 Questions
Exam 3: Quantitative Demand Analysis170 Questions
Exam 4: The Theory of Individual Behavior179 Questions
Exam 5: The Production Process and Costs173 Questions
Exam 6: The Organization of the Firm157 Questions
Exam 7: The Nature of Industry123 Questions
Exam 8: Managing in Competitive, Monopolistic, and Monopolistically Competitive Markets130 Questions
Exam 9: Basic Oligopoly Models134 Questions
Exam 10: Game Theory: Inside Oligopoly140 Questions
Exam 11: Pricing Strategies for Firms With Market Power140 Questions
Exam 12: The Economics of Information128 Questions
Exam 13: Advanced Topics in Business Strategy89 Questions
Exam 14: A Managers Guide to Government in the Marketplace112 Questions
Select questions type
You are the manager of a firm that has an exclusive license to produce your product. The inverse market demand curve is P = 900 - 1.5Q. Your cost function is C(Q) = 2Q + Q2. Determine the output you should produce, the price you should charge, and your profits.
(Essay)
4.9/5
(76)
The second-order condition for a firm maximizing its profits operating in a perfectly competitive market is:
(Multiple Choice)
4.9/5
(75)
You are the manager of a monopoly firm with (inverse) demand given by P = 50 - 0.5Q. Your firm's cost function is C = 40 + 5Q2. Your firm's marginal revenue is:
(Multiple Choice)
4.8/5
(77)
The second-order condition for a monopoly maximizing its profit is:
(Multiple Choice)
4.8/5
(87)
Consider a monopoly where the inverse demand for its product is given by P = 80 - 2Q. Total costs for this monopolist are estimated to be C(Q) = 100 + 20Q + Q2. At the profit-maximizing combination of output and price, deadweight loss is:
(Multiple Choice)
4.9/5
(88)
The second-order condition for a firm maximizing its profit operating in a monopolistically competitive market is:
(Multiple Choice)
4.8/5
(72)
Genentech owns a patent on tissue plasminogen activator (TPA), which is an enzyme that helps the body break down blood clots. TPA is particularly valuable to cardiac patients, since it often allows heart problems to be treated with medication rather than surgery. Recently, however, firms in the medical industry have come under fire from some members of Congress and the press for charging high prices and earning monopoly profits. Do you think cardiac patients would benefit if the government stripped Genentech and other pharmaceutical firms of their patents? Explain.
(Essay)
4.8/5
(90)
A monopoly has produced a product with a patent for the last few years. The patent is going to expire. What will likely happen to the demand for the patent-holder's product when the patent runs out?
(Multiple Choice)
5.0/5
(81)
Showing 121 - 130 of 130
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)